 SAN CARLOS, Calif., Jan. 14, 2021 PRNewswire -- Natera, Inc. NASDAQ: NTRA, a pioneer and global leader in cell-free DNA cfDNA testing, today announced it will present new data on the Prospera test at the American Society of Transplant Surgeons ASTS 21st Annual Winter Symposium,... 